S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

MRO Acquires Vyne Medical to Automate Clinical Data Workflows

Norristown-based MRO has acquired Vyne Medical, integrating automated document processing into its clinical data management platform to serve over 2,500 hospitals. The move aims to convert fragmented information trapped in faxes, voice notes, and paper records into structured, actionable digital data for healthcare providers nationwide.

MRO Acquires Vyne Medical to Automate Clinical Data Workflows
Photo: Bio & News

The acquisition brings Vyne Medical’s intelligent intake capabilities into the MRO ecosystem, addressing a critical bottleneck in health systems where essential information remains hidden outside the electronic medical record (EMR). By combining automated classification and extraction with human oversight, the company plans to streamline high-volume workflows while reducing the manual rekeying of data that currently burdens hospital staff.

Jason Brown, CEO of MRO, noted that capturing information at the point of entry allows providers to curate structured data before it enters clinical or financial workflows. This shift is designed to improve turnaround times and increase the visibility of patient data across disparate systems. Following the deal, Vyne Medical will operate as an MRO company, supporting a combined network of 35,000 clinics. The transaction excludes Vyne Dental, which remains with its original portfolio company, TJC, L.P. Financial details regarding the purchase were not disclosed.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!